Alcoholic Hepatitis: Pathogenesis, Diagnosis and Treatment

Area of Science:

• Hepatology
• Gastroenterology
• Toxicology

Background:

• Alcoholic Liver Disease (ALD) is the most prevalent cause of chronic liver disease globally.
• ALD encompasses a spectrum of liver damage, progressing from steatosis to cirrhosis.
• Diagnosis relies on alcohol consumption history and clinical/laboratory findings.

Purpose of the Study:

• To review the current therapeutic landscape for Alcoholic Liver Disease.
• To highlight the challenges in treating severe Alcoholic Hepatitis (AH).
• To identify unmet needs in long-term ALD management, particularly fibrosis prevention.

Main Methods:

• Literature review of ALD and Alcoholic Hepatitis (AH) pathogenesis and treatment.
• Analysis of current therapeutic guidelines for severe AH.
• Examination of the status of long-term fibrosis-halting treatments for ALD.

Main Results:

• Abstinence remains the primary therapy for ALD.
• Glucocorticoids and pentoxifylline are recommended for severe acute AH.
• No specific long-term treatments are approved to stop ALD-related fibrosis progression.

Conclusions:

• ALD poses a significant health burden with limited therapeutic advancements.
• Severe AH requires specific interventions, but long-term fibrosis management remains a critical unmet need.
• Further research into disease-modifying therapies for ALD is essential.